Condition
Overweight
Obesity
Locations
Japan
Start date
07/09/2026
Identifiers
Trial ID NN9490-8088,
NCT number NCT07822061,
Eudract number Not Available
NCT number NCT07822061,
Eudract number Not Available
Summary
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people with excess body weight and to compare its effects with placebo. Participants will receive either NNC0487-0111, the treatment being tested, or placebo, a treatment with no active medicine. Which treatment participants receive is decided by chance. NNC0487-0111 is a new medicine that doctors cannot yet prescribe, but it has been tested in humans before.
Trial Overview:
Treatment
DRUG: NNC0487-0111
DRUG: Placebo (matched to NNC0487-0111)
Study type
INTERVENTIONAL
Trial duration
Sep 07 2026 - Feb 05 2029
Participants
400
Phase
III
Are you eligible?
Gender
Male and female
Age
18 years and older
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.